Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukaemia

• Toby A. Eyre,
• Nicole Lamanna,
• Lindsey E. Roeker,
• Chaitra S. Ujjani,
• Brian T. Hill,
• Paul M. Barr,
• Erick Lansigan,
• Bruce D. Cheson,
• Maryam Yazdy,
• John N. Allan,
• Joanna Rhodes,
• Stephen J. Schuster,
• Chadi Nabhan,
• Alan Skarbnik,
• Lori Leslie,
• Prioty Islam,
• Katherine Whitaker,
• Catherine C. Coombs,
• Hande H. Tuncer,
• John M. Pagel,
• Ryan Jacobs,
• Allison M. Winter,
• Neil Bailey,
• Andrea Sitlinger,
• Anna H. Schuh,
• George Follows,
• Christopher P. Fox,
• Danielle M. Brander,
• Mazyar Shadman,
• Anthony R. Mato

Affiliations

Toby A. Eyre

Hematology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford

Nicole Lamanna

New York-Presbyterian Columbia University Medical Center, New York, NY

Lindsey E. Roeker

Memorial Sloan Kettering Cancer Center, New York, NY,

Chaitra S. Ujjani

Seattle Cancer Care Alliance/Fred Hutchinson Cancer Research Center, Seattle, WA;

Brian T. Hill

Dept. of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation,

Paul M. Barr

Division of Hematology/Oncology, Wilmot Cancer Institute, University of Rochester, Rochester, NY

Erick Lansigan

Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA;

Bruce D. Cheson

Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC,

Maryam Yazdy

Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC,

John N. Allan

Weill Cornell Medicine School of Medicine, Long Island City, NY;

Joanna Rhodes

Div. of Hematology and Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA

Stephen J. Schuster

Div of Hematology and Oncology,Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA

Chadi Nabhan

Aptitude Health, Atlanta, GA,

Alan Skarbnik

Novant Health, Charlotte, NC,

Lori Leslie

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ,

Prioty Islam

Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC

Katherine Whitaker

Memorial Sloan Kettering Cancer Center, New York, NY,

Catherine C. Coombs

Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC,

Hande H. Tuncer

Department of Medicine, Cancer Center, Tufts Medical Center, Boston, MA

John M. Pagel

Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA,

Ryan Jacobs

Department of Hematology, Lymphoma Division, Levine Cancer Institute, Charlotte, NC,

Allison M. Winter

Dept of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation

Neil Bailey

Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA,

Andrea Sitlinger

Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC,

Anna H. Schuh

Haematology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford,

George Follows

Department of Haematology, Addenbrookes, Cambridge,

Christopher P. Fox

Nottingham University Hospitals NHS Trust, Nottingham,

Danielle M. Brander

Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC,

Mazyar Shadman

Seattle Cancer Care Alliance/Fred Hutchinson Cancer Research Center, Seattle, WA

Anthony R. Mato

Memorial Sloan Kettering Cancer Center, New York, NY